2022 Q3 Form 10-Q Financial Statement
#000095012322009538 Filed on August 15, 2022
Income Statement
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | |||
| YoY Change | |||
| % of Gross Profit | |||
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | |||
| YoY Change | |||
| % of Gross Profit | |||
| Operating Expenses | $364.1K | $543.5K | $602.1K |
| YoY Change | -19.2% | 302.23% | 567.46% |
| Operating Profit | -$364.1K | -$543.5K | -$602.1K |
| YoY Change | -19.2% | 302.23% | 567.46% |
| Interest Expense | $1.296M | $374.4K | $72.45K |
| YoY Change | 4586.59% | 2308.94% | 79.96% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $1.334M | $3.298M | $1.820M |
| YoY Change | 4724.5% | 21123.24% | 4420.4% |
| Pretax Income | $970.2K | $2.754M | $1.218M |
| YoY Change | -329.4% | -2403.01% | -2537.92% |
| Income Tax | $294.1K | $22.64K | |
| % Of Pretax Income | 30.31% | 0.82% | |
| Net Earnings | $676.1K | $2.732M | $1.218M |
| YoY Change | -259.87% | -2384.08% | -2537.71% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | $0.02 | $0.08 | $0.04 |
| Diluted Earnings Per Share | $0.02 | $0.08 | $0.04 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 34.50M | 6.900M | 6.900M |
| Diluted Shares Outstanding | 6.900M | 6.900M | 6.900M |
Balance Sheet
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $30.85K | $123.6K | $247.7K |
| YoY Change | -94.24% | -81.48% | -66.05% |
| Cash & Equivalents | $30.85K | $123.6K | $247.7K |
| Short-Term Investments | |||
| Other Short-Term Assets | $123.2K | $153.1K | $212.2K |
| YoY Change | -54.97% | -45.66% | -27.47% |
| Inventory | |||
| Prepaid Expenses | $123.2K | $153.1K | |
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $154.0K | $276.8K | $459.9K |
| YoY Change | -80.97% | -70.85% | -55.01% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | |||
| YoY Change | |||
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $277.7M | $276.4M | $276.0M |
| YoY Change | 0.54% | 0.07% | -0.08% |
| Total Long-Term Assets | $277.7M | $276.4M | $276.0M |
| YoY Change | 0.54% | 0.07% | -0.08% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $154.0K | $276.8K | $459.9K |
| Total Long-Term Assets | $277.7M | $276.4M | $276.0M |
| Total Assets | $277.8M | $276.7M | $276.5M |
| YoY Change | 0.3% | -0.17% | -0.28% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | |||
| YoY Change | |||
| Accrued Expenses | $3.686M | $3.613M | $3.283M |
| YoY Change | 1414.07% | 43696.73% | 28823.35% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $250.0K | $150.0K | $150.0K |
| YoY Change | 66.67% | 0.0% | 0.0% |
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $4.361M | $3.865M | $3.482M |
| YoY Change | 885.79% | 2080.58% | 1830.72% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $9.996M | $10.03M | $12.96M |
| YoY Change | 3.48% | 3.87% | 34.13% |
| Total Long-Term Liabilities | $9.996M | $10.03M | $12.96M |
| YoY Change | 3.48% | 3.87% | 34.13% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.361M | $3.865M | $3.482M |
| Total Long-Term Liabilities | $9.996M | $10.03M | $12.96M |
| Total Liabilities | $14.36M | $13.90M | $16.44M |
| YoY Change | 42.11% | 41.29% | 67.06% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$13.74M | -$13.46M | -$15.95M |
| YoY Change | 54.86% | 86.1% | |
| Common Stock | $690.00 | $690.00 | $690.00 |
| YoY Change | 0.0% | -99.99% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$13.74M | -$13.46M | -$15.95M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $277.8M | $276.7M | $276.5M |
| YoY Change | 0.3% | -0.17% | -0.28% |
Cashflow Statement
| Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $676.1K | $2.732M | $1.218M |
| YoY Change | -259.87% | -2384.08% | -2537.71% |
| Depreciation, Depletion And Amortization | |||
| YoY Change | |||
| Cash From Operating Activities | -$231.8K | -$124.1K | -$375.6K |
| YoY Change | 98.53% | 99.86% | -10.56% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | |||
| YoY Change | |||
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $39.00K | $0.00 | $161.0K |
| YoY Change | -100.06% | ||
| Cash From Investing Activities | $39.00K | $0.00 | $161.0K |
| YoY Change | -100.06% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 100.0K | 0.000 | 0.000 |
| YoY Change | -768.9% | -100.0% | |
| NET CHANGE | |||
| Cash From Operating Activities | -231.8K | -124.1K | -375.6K |
| Cash From Investing Activities | 39.00K | 0.000 | 161.0K |
| Cash From Financing Activities | 100.0K | 0.000 | 0.000 |
| Net Change In Cash | -92.80K | -124.1K | -214.6K |
| YoY Change | -29.54% | 99.86% | -130.92% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$231.8K | -$124.1K | -$375.6K |
| Capital Expenditures | |||
| Free Cash Flow | |||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| adex |
Number Of Trading Days
NumberOfTradingDays
|
P20D | ||
| adex |
Number Of Consecutive Trading Days
NumberOfConsecutiveTradingDays
|
P30D | ||
| adex |
Warrants Redemption Covenant Threshold Trading Days
WarrantsRedemptionCovenantThresholdTradingDays
|
P20D | ||
| adex |
Warrants Redemption Covenant Threshold Consecutive Trading Days
WarrantsRedemptionCovenantThresholdConsecutiveTradingDays
|
P30D | ||
| adex |
Number Of Business Days Before Sending Notice Of Redemption Period
NumberOfBusinessDaysBeforeSendingNoticeOfRedemptionPeriod
|
P3D | ||
| adex |
Number Of Trading Days Prior On Consummates Business Combination
NumberOfTradingDaysPriorOnConsummatesBusinessCombination
|
P10D | ||
| CY2022Q2 | adex |
Weighted Average Redeemable Common Diluted
WeightedAverageRedeemableCommonDiluted
|
27600000 | |
| CY2021Q2 | adex |
Weighted Average Redeemable Common Diluted
WeightedAverageRedeemableCommonDiluted
|
27600000 | |
| adex |
Weighted Average Redeemable Common Diluted
WeightedAverageRedeemableCommonDiluted
|
27600000 | ||
| adex |
Weighted Average Redeemable Common Diluted
WeightedAverageRedeemableCommonDiluted
|
25365746 | ||
| CY2022Q2 | adex |
Earnings Per Share Redeemable Common Stock Diluted
EarningsPerShareRedeemableCommonStockDiluted
|
0.08 | |
| CY2021Q2 | adex |
Earnings Per Share Redeemable Common Stock Diluted
EarningsPerShareRedeemableCommonStockDiluted
|
0.00 | |
| adex |
Earnings Per Share Redeemable Common Stock Diluted
EarningsPerShareRedeemableCommonStockDiluted
|
0.11 | ||
| CY2022Q2 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
276401240 | |
| CY2022Q2 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
276376091 | |
| CY2021Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y5M4D | |
| CY2021 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y4M24D | |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | ||
| CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.08 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.11 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | ||
| CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
2754147 | |
| CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22636 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6900000 | |
| CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6900000 | |
| CY2021Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
135127 | |
| CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-543520 | |
| CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-135127 | |
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4670740 | ||
| CY2022Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
374346 | |
| CY2021Q2 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
15538 | |
| CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
3297667 | |
| CY2021Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
15538 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
22636 | ||
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2731511 | |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-119589 | |
| CY2022Q2 | adex |
Weighted Average Redeemable Common Basic And Diluted
WeightedAverageRedeemableCommonBasicAndDiluted
|
27600000 | |
| adex |
Weighted Average Redeemable Common Basic And Diluted
WeightedAverageRedeemableCommonBasicAndDiluted
|
27600000 | ||
| adex |
Weighted Average Redeemable Common Basic And Diluted
WeightedAverageRedeemableCommonBasicAndDiluted
|
25365746 | ||
| CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.00 | |
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.11 | ||
| us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
-0.01 | ||
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
6900000 | ||
| CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.08 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.00 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.11 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | ||
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-15952062 | |
| CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
2731511 | |
| CY2022Q2 | us-gaap |
Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
|
239154 | |
| CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13459705 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24474 | |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
7270000 | |
| CY2021Q1 | adex |
Subsequent Measurements
SubsequentMeasurements
|
-15816086 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-49954 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8571566 | |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-119589 | |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8691155 | |
| us-gaap |
Profit Loss
ProfitLoss
|
3949247 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-169543 | ||
| us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-4670740 | ||
| adex |
Interest Earned On Cash And Marketable Securities Held In Trust Account
InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount
|
446796 | ||
| adex |
Interest Earned On Cash And Marketable Securities Held In Trust Account
InterestEarnedOnCashAndMarketableSecuritiesHeldInTrustAccount
|
55797 | ||
| us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-126541 | ||
| us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
422752 | ||
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
22636 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
459478 | ||
| us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
165885 | ||
| us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
60000 | ||
| us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
213 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-499634 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-481994 | ||
| adex |
Investment Held In Trust Account
InvestmentHeldInTrustAccount
|
276000000 | ||
| adex |
Cash Withdrawn From Trust Account To Pay Franchise Tax And Income Taxes
CashWithdrawnFromTrustAccountToPayFranchiseTaxAndIncomeTaxes
|
161000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
161000 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-276000000 | ||
| adex |
Proceeds From Initial Public Offering Net Of Underwriters Fees
ProceedsFromInitialPublicOfferingNetOfUnderwritersFees
|
270480000 | ||
| us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
7270000 | ||
| adex |
Payments Of Offering Costs
PaymentsOfOfferingCosts
|
636086 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
277113914 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-338634 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
631920 | ||
| CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
462274 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
35614 | |
| CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
123640 | |
| CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
667534 | |
| adex |
Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
|
9660000 | ||
| adex |
Initial Value Of Common Stock Subject To Possible Redemption
InitialValueOfCommonStockSubjectToPossibleRedemption
|
276000000 | ||
| adex |
Noncash Accretion Of Carrying Value To Redemption Value
NoncashAccretionOfCarryingValueToRedemptionValue
|
239154 | ||
| adex |
Deferred Offering Costs Paid By Sponsor Loan
DeferredOfferingCostsPaidBySponsorLoan
|
18773 | ||
| CY2021Q1 | adex |
Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
|
6550000 | |
| CY2021Q1 | adex |
Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
|
1.00 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
6550000 | |
| CY2021Q1 | adex |
Period Of Underwriters Option To Purchase Units
PeriodOfUnderwritersOptionToPurchaseUnits
|
P45D | |
| CY2021Q1 | adex |
Deferred Underwriting Fees
DeferredUnderwritingFees
|
720000 | |
| CY2021Q1 | adex |
Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
|
720000 | |
| CY2021Q1 | adex |
Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
|
1.00 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
720000 | |
| CY2021Q1 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
13836086 | |
| CY2021Q1 | adex |
Underwriting Discount
UnderwritingDiscount
|
4800000 | |
| CY2021Q1 | adex |
Deferred Underwriting Discount
DeferredUnderwritingDiscount
|
8400000 | |
| CY2021Q1 | adex |
Other Offering Costs
OtherOfferingCosts
|
636086 | |
| CY2021Q1 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
276000000 | |
| CY2022Q2 | adex |
Anticipated Stock Redemption Price Per Share
AnticipatedStockRedemptionPricePerShare
|
10.00 | |
| CY2022Q2 | adex |
Business Combination Minimum Threshold Limit Of Net Intangible Assets Required
BusinessCombinationMinimumThresholdLimitOfNetIntangibleAssetsRequired
|
5000001 | |
| adex |
Restriction On Public Share Redemption In Case Of Stockholder Approval Of Business Combination
RestrictionOnPublicShareRedemptionInCaseOfStockholderApprovalOfBusinessCombination
|
0.15 | ||
| adex |
Business Combination Incomplete Percentage Of Stock Redemption
BusinessCombinationIncompletePercentageOfStockRedemption
|
1 | ||
| adex |
Business Combination Completion Date Of Acquisition
BusinessCombinationCompletionDateOfAcquisition
|
2023-01-14 | ||
| CY2022Q2 | adex |
Business Combination Incomplete Maximum Dissolution Expenses To Be Paid
BusinessCombinationIncompleteMaximumDissolutionExpensesToBePaid
|
100000 | |
| adex |
Price Per Share Reduction To Amount Held In Trust
PricePerShareReductionToAmountHeldInTrust
|
10.00 | ||
| CY2022Q2 | adex |
Operating Bank Account Balance
OperatingBankAccountBalance
|
100000 | |
| CY2022Q2 | adex |
Working Capital Deficit
WorkingCapitalDeficit
|
3400000 | |
| CY2022Q2 | adex |
Franchise Tax Payable
FranchiseTaxPayable
|
139450 | |
| CY2022Q2 | us-gaap |
Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
|
22636 | |
| CY2022Q2 | adex |
Operating Bank Account Balance
OperatingBankAccountBalance
|
100000 | |
| CY2021Q4 | us-gaap |
Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
|
276119979 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.1320 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0121 | |
| us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of unaudited condensed <span style="color:#000000;">consolidated </span>financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed <span style="color:#000000;">consolidated f</span>inancial statements and the reported amounts of revenues and expenses during the reporting periods.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed <span style="color:#000000;">consolidated </span>financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | ||
| us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-weight:bold;color:#000000;font-size:10pt;">Concentration of Credit Risk</span></p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At <span style="color:#000000;">June 30, 2022</span> and December 31, <span style="color:#000000;">2021</span>, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> | ||
| us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | ||
| CY2022Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
27600000 | |
| CY2021Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
27600000 | |
| CY2022Q2 | adex |
Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption
AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption
|
2150495 | |
| CY2022Q2 | adex |
Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption
AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption
|
537624 | |
| CY2021Q2 | adex |
Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption
AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption
|
-95671 | |
| adex |
Allocation Of Net Loss Including Shares Of Redeemable Common Stock Subject To Possible Redemption
AllocationOfNetLossIncludingSharesOfRedeemableCommonStockSubjectToPossibleRedemption
|
3124684 | ||
| adex |
Allocation Of Net Loss Including Shares Of Common Stock Subject To Possible Redemption
AllocationOfNetLossIncludingSharesOfCommonStockSubjectToPossibleRedemption
|
-36257 | ||
| CY2022Q2 | adex |
Weighted Average Redeemable Common Basic And Diluted
WeightedAverageRedeemableCommonBasicAndDiluted
|
27600000 | |
| CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | |
| CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | |
| adex |
Weighted Average Redeemable Common Basic And Diluted
WeightedAverageRedeemableCommonBasicAndDiluted
|
25365746 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6900000 | ||
| CY2022Q2 | adex |
Earnings Per Share Redeemable Common Stock Basic
EarningsPerShareRedeemableCommonStockBasic
|
0.08 | |
| CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.08 | |
| CY2021Q2 | adex |
Earnings Per Share Redeemable Common Stock Basic
EarningsPerShareRedeemableCommonStockBasic
|
0.00 | |
| CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.00 | |
| adex |
Earnings Per Share Redeemable Common Stock Basic
EarningsPerShareRedeemableCommonStockBasic
|
0.11 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | ||
| adex |
Earnings Per Share Redeemable Common Stock Basic
EarningsPerShareRedeemableCommonStockBasic
|
-0.01 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | ||
| CY2022Q2 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.00 | |
| CY2022Q2 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
4218 | |
| CY2021Q4 | us-gaap |
Held To Maturity Securities
HeldToMaturitySecurities
|
276115444 | |
| CY2021Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
4535 | |
| us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Derivative Financial Instruments</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Stock (“ASC 815-40”).” The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At June 30, 2022 and December 31, 2021, the Company has evaluated both the Public Warrants (as defined below) and Private Placement Warrants under ASC 480 and ASC 815-40. <span style="color:#000000;">Such guidance provides that because the Private Placement Warrants do not meet the criteria for equity treatment thereunder, each Private Placement Warrant must be recorded as a liability. Accordingly, the Company classified each Private Placement Warrant as a liability at its fair value. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s condensed statements of operations. The Private Placement Warrants had met the requirement for equity accounting treatment when initially issued. On the date of IPO, the Company’s Private Placement Warrants met the criteria for equity classification. On December 23, 2021, the Private Placement Warrants were modified such that the Private Placement Warrants no longer meet the criteria for equity treatment. As such, the Private Placement Warrants were treated as derivative liability instruments from the date of the modification.</span></p> | ||
| CY2022Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0240 | |
| CY2021Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0166 | ||
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.0000 | ||
| CY2022Q2 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| CY2021Q2 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | |
| us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | ||
| us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | ||
| adex |
Share Holding Period Upon Closing Of Business Combination
ShareHoldingPeriodUponClosingOfBusinessCombination
|
P1Y | ||
| CY2022Q2 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
12.00 | |
| adex |
Minimum Share Holding Period Upon Closing Of Business Combination
MinimumShareHoldingPeriodUponClosingOfBusinessCombination
|
P150D | ||
| CY2021Q2 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
400000 | |
| CY2021Q2 | adex |
Related Party Transaction Units Profit Interest Percentage
RelatedPartyTransactionUnitsProfitInterestPercentage
|
0.005 | |
| us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
276000000 | ||
| adex |
Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
|
16771351 | ||
| us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
14849933 | ||
| CY2021Q4 | adex |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
31621284 | |
| CY2021Q4 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
276000000 | |
| CY2022Q2 | adex |
Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
|
239154 | |
| CY2022Q2 | us-gaap |
Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
|
276239154 | |
| CY2021Q1 | adex |
Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
|
6550000 | |
| CY2021Q1 | adex |
Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
|
1.00 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
6550000 | |
| CY2021Q1 | adex |
Sale Of Private Placement Warrants
SaleOfPrivatePlacementWarrants
|
720000 | |
| CY2021Q1 | adex |
Cost Of Per Private Placement Warrant
CostOfPerPrivatePlacementWarrant
|
1.00 | |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
720000 | |
| CY2021Q2 | us-gaap |
Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
|
The cash payment will become due and payable on the earlier to occur of: (i) April 26, 2022 and (ii) the date on which GRIID consummates a merger with a special purpose acquisition company, qualified initial public offering, or other change of control transaction (each, a “qualifying transaction”). | |
| CY2021Q2 | us-gaap |
Related Party Transaction Date
RelatedPartyTransactionDate
|
2022-04-26 | |
| adex |
Related Party Transaction Vesting Description
RelatedPartyTransactionVestingDescription
|
The units will vest as to one-fourth on April 16, 2022, and 1/36th on the 17th day of each month thereafter, subject to such entity’s continued service through such vesting dates; provided, however, that any unvested units shall fully vest upon a qualifying transaction. | ||
| adex |
Proceeds From Related Parties
ProceedsFromRelatedParties
|
80000 | ||
| CY2021 | adex |
Proceeds From Related Parties
ProceedsFromRelatedParties
|
20000 | |
| CY2021Q4 | us-gaap |
Share Price
SharePrice
|
9.88 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
11.50 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.045 | ||
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.1170 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0301 | ||
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0120 | |
| CY2022Q2 | us-gaap |
Share Price
SharePrice
|
9.84 | |
| CY2021Q4 | us-gaap |
Share Price
SharePrice
|
9.90 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | ||
| CY2021 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | |
| CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
11.50 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
11.50 | |
| adex |
Registration Rights Agreement Term
RegistrationRightsAgreementTerm
|
The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of the Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration rights agreement signed on January 11, 2021, requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. | ||
| adex |
Registration Rights Agreement Date
RegistrationRightsAgreementDate
|
2021-01-11 | ||
| CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q2 | adex |
Common Stock Shares Issued Including Shares Subject To Possible Redemption
CommonStockSharesIssuedIncludingSharesSubjectToPossibleRedemption
|
34500000 | |
| CY2022Q2 | adex |
Common Stock Shares Outstanding Including Shares Subject To Possible Redemption
CommonStockSharesOutstandingIncludingSharesSubjectToPossibleRedemption
|
34500000 | |
| CY2021Q4 | adex |
Common Stock Shares Issued Including Shares Subject To Possible Redemption
CommonStockSharesIssuedIncludingSharesSubjectToPossibleRedemption
|
34500000 | |
| CY2021Q4 | adex |
Common Stock Shares Outstanding Including Shares Subject To Possible Redemption
CommonStockSharesOutstandingIncludingSharesSubjectToPossibleRedemption
|
34500000 | |
| CY2022Q2 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
27600000 | |
| CY2021Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
27600000 | |
| adex |
Warrants Exercisable Period After Completion Of Business Combination
WarrantsExercisablePeriodAfterCompletionOfBusinessCombination
|
P30D | ||
| adex |
Warrant Expiration Period After Completion Of Business Combination Earlier Upon Redemption Liquidation
WarrantExpirationPeriodAfterCompletionOfBusinessCombinationEarlierUponRedemptionLiquidation
|
P5Y | ||
| CY2022Q2 | adex |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
0 | |
| CY2022Q2 | adex |
Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
|
0.01 | |
| adex |
Minimum Period Of Prior Written Notice Of Redemption Of Warrants
MinimumPeriodOfPriorWrittenNoticeOfRedemptionOfWarrants
|
P30D | ||
| CY2022Q2 | adex |
Minimum Price Per Share Required For Redemption Of Warrants
MinimumPricePerShareRequiredForRedemptionOfWarrants
|
18.00 | |
| CY2022Q2 | adex |
Redemption Triggering Price Of Warrants
RedemptionTriggeringPriceOfWarrants
|
18.00 | |
| CY2022Q2 | adex |
Class Of Warrants Redemption Exercise Price Per Share
ClassOfWarrantsRedemptionExercisePricePerShare
|
11.50 | |
| CY2022Q2 | adex |
Maximum Effective Issue Price To Closing Of Business Combination
MaximumEffectiveIssuePriceToClosingOfBusinessCombination
|
9.20 | |
| CY2022Q2 | adex |
Minimum Percentage Of Equity Proceeds From Issuances
MinimumPercentageOfEquityProceedsFromIssuances
|
0.60 | |
| CY2022Q2 | adex |
Percentage Of Exercise Price Of Warrants Adjusted Equal To Higher Of Market Value And Newly Issued Price
PercentageOfExercisePriceOfWarrantsAdjustedEqualToHigherOfMarketValueAndNewlyIssuedPrice
|
1.15 | |
| CY2022Q2 | adex |
Redemption Triggering Price Of Warrants
RedemptionTriggeringPriceOfWarrants
|
18.00 | |
| CY2022Q2 | adex |
Percentage Of Warrant Redemption Trigger Price Adjusted Equal To Higher Of Market Value And Newly Issued Price
PercentageOfWarrantRedemptionTriggerPriceAdjustedEqualToHigherOfMarketValueAndNewlyIssuedPrice
|
1.80 | |
| CY2022Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-2923321 | |
| CY2022Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2022Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
| CY2022Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
| CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | |
| CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6900000 | |
| CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
6900000 | |
| CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
543520 |
